These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 27908572)

  • 21. The use of ketamine in electroconvulsive therapy.
    Kucia K; Merk W
    Psychiatr Pol; 2015; 49(6):1255-63. PubMed ID: 26909400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A systematic review and meta-analysis of randomized controlled trials of adjunctive ketamine in electroconvulsive therapy: efficacy and tolerability.
    McGirr A; Berlim MT; Bond DJ; Neufeld NH; Chan PY; Yatham LN; Lam RW
    J Psychiatr Res; 2015 Mar; 62():23-30. PubMed ID: 25684151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of ketamine vs. ECT in major depressive disorder: need for ECT standard dosing and duration parameters.
    Campion P
    Psychiatry Res; 2015 Jan; 225(1-2):216. PubMed ID: 25511507
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparing effects of ketamine and thiopental administration during electroconvulsive therapy in patients with major depressive disorder: a randomized, double-blind study.
    Yoosefi A; Sepehri AS; Kargar M; Akhondzadeh S; Sadeghi M; Rafei A; Alimadadi A; Ghaeli P
    J ECT; 2014 Mar; 30(1):15-21. PubMed ID: 24091902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anesthesia for electroconvulsive therapy.
    Soehle M; Bochem J
    Curr Opin Anaesthesiol; 2018 Oct; 31(5):501-505. PubMed ID: 29994943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repetitive transcranial magnetic stimulation versus electroconvulsive therapy for major depression: a systematic review and meta-analysis.
    Ren J; Li H; Palaniyappan L; Liu H; Wang J; Li C; Rossini PM
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jun; 51():181-9. PubMed ID: 24556538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum BDNF as a peripheral biomarker of treatment-resistant depression and the rapid antidepressant response: A comparison of ketamine and ECT.
    Allen AP; Naughton M; Dowling J; Walsh A; Ismail F; Shorten G; Scott L; McLoughlin DM; Cryan JF; Dinan TG; Clarke G
    J Affect Disord; 2015 Nov; 186():306-11. PubMed ID: 26275358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ketamine versus electroconvulsive therapy for major depressive episode: An updated systematic review and non-inferiority meta-analysis.
    Petrucci ABC; Fernandes JVA; Reis IA; da Silva GHS; Recla BMF; de Mendonça JC; Pedro VCS; D'Assunção LEN; Valiengo LDCL
    Psychiatry Res; 2024 Sep; 339():115994. PubMed ID: 38865906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative efficacy and tolerability of different anesthetics in electroconvulsive therapy for major depressive disorder: A systematic review and network meta-analysis.
    Ren L; Yu J; Zeng J; Wei K; Li P; Luo J; Shen Y; Lv F; Min S
    J Psychiatr Res; 2024 Mar; 171():116-125. PubMed ID: 38271762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ketamine appears associated with better word recall than etomidate after a course of 6 electroconvulsive therapies.
    McDaniel WW; Sahota AK; Vyas BV; Laguerta N; Hategan L; Oswald J
    J ECT; 2006 Jun; 22(2):103-6. PubMed ID: 16801824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ketamine-based anesthesia improves electroconvulsive therapy outcomes: a randomized-controlled study.
    Gamble JJ; Bi H; Bowen R; Weisgerber G; Sanjanwala R; Prasad R; Balbuena L
    Can J Anaesth; 2018 Jun; 65(6):636-646. PubMed ID: 29700801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and Safety of Ketamine vs Electroconvulsive Therapy Among Patients With Major Depressive Episode: A Systematic Review and Meta-analysis.
    Rhee TG; Shim SR; Forester BP; Nierenberg AA; McIntyre RS; Papakostas GI; Krystal JH; Sanacora G; Wilkinson ST
    JAMA Psychiatry; 2022 Dec; 79(12):1162-1172. PubMed ID: 36260324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparing the Anti-Depressive Effect of Electroconvulsive Therapy (ECT) Versus Transcranial Magnetic Stimulation (TMS) in the Treatment of Patients with Depression.
    Chigareva O; Smirnova D; Astafeva D; Gradinar A; Izmailova O; Sheyfer M; Cumming P; Sack A; Gayduk AJ
    Psychiatr Danub; 2023 Oct; 35(Suppl 2):48-55. PubMed ID: 37800203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of ketamine-assisted electroconvulsive therapy in major depressive episode: a systematic review and network meta-analysis.
    Rhee TG; Shim SR; Popp JH; Trikalinos TA; Rosenheck RA; Kellner CH; Seiner SJ; Espinoza RT; Forester BP; McIntyre RS
    Mol Psychiatry; 2024 Mar; 29(3):750-759. PubMed ID: 38123725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression.
    Ibrahim L; Diazgranados N; Luckenbaugh DA; Machado-Vieira R; Baumann J; Mallinger AG; Zarate CA
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):1155-9. PubMed ID: 21466832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression.
    Newport DJ; Carpenter LL; McDonald WM; Potash JB; Tohen M; Nemeroff CB;
    Am J Psychiatry; 2015 Oct; 172(10):950-66. PubMed ID: 26423481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ketamine plus propofol-electroconvulsive therapy (ECT) transiently improves the antidepressant effects and the associated brain functional alterations in patients with propofol-ECT-resistant depression.
    Zhang J; Tian H; Li J; Ji S; Chen S; Zhu J; Jiang D; Wang L; Li G; Chen M; Wang W; Lin X; Zhuo C
    Psychiatry Res; 2020 May; 287():112907. PubMed ID: 32179210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Augmentation strategies in electroconvulsive therapy.
    Loo C; Simpson B; MacPherson R
    J ECT; 2010 Sep; 26(3):202-7. PubMed ID: 20562640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Robust Antidepressant Effect Following Alternating Intravenous Racemic Ketamine and Electroconvulsive Therapy in Treatment-Resistant Depression: A Case Report.
    Bartova L; Weidenauer A; Dold M; Naderi-Heiden A; Kasper S; Willeit M; Praschak-Rieder N
    J ECT; 2017 Sep; 33(3):e31-e32. PubMed ID: 28520578
    [No Abstract]   [Full Text] [Related]  

  • 40. Alcohol Use Disorder as a Possible Predictor of Electroconvulsive Therapy Response.
    Aksay SS; Hambsch M; Janke C; Bumb JM; Kranaster L; Sartorius A
    J ECT; 2017 Jun; 33(2):117-121. PubMed ID: 27828926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.